Delhi reports 19 fresh Covid-19 cases, lowest single-day this year

Delhi on Saturday reported a total of 19 fresh Covid case, the lowest daily caseload in this year, according to data shared by the city health department

Topics
Coronavirus Vaccine | Coronavirus

IANS  |  New Delhi 

coronavirus, covid-19, vaccine, vaccination
Photo: Bloomberg

The national capital on Saturday reported a total of 19 fresh Covid case, the lowest daily caseload in this year, according to data shared by the city health department. The new cases take the total tally to 14,37,293 in the city.

The death toll remains at 25,079 as no death due to Covid-19 was recorded for the second consecutive day in Delhi.

This is the twelfth time since the starting of the second wave of the pandemic in the national capital that zero fatality has been logged in a day. On July 18, July 24, July 29, August 2, August 4, August 8, August 11, August 12, August 13, August 16 and August 20 too, no death due to Covid-19 was reported, according to official data.

Total 48 Covid patients were discharged in the last 24 hours, taking the total number of recoveries to 14,11,784, the bulletin said. The total number of active cases in the capital stands at 430, and 132 of them are being treated in home isolation.

According to the bulletin, the city has achieved 0.03 per cent Covid infection rate for the first time, while the recovery rate continues to be at 98.22 per cent. The death rate stands at 1.74 per cent.

Meanwhile, a total of 59,740 new tests were conducted including 47,534 RT-PCR tests and 12,206 Rapid Antigen tests, taking the total number to 2,50,42,978 so far. As per the bulletin, there are 239 containment zones.

The markets in the national capital can stay open beyond 8 pm from August 23, as the Delhi government on Saturday announced the lifting of restrictions in view of a decline in Covid-19 cases in the city.

--IANS

avr/rs

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Sun, August 22 2021. 08:23 IST
RECOMMENDED FOR YOU